Skin Cancer Whole Blood
About: Skin Cancer Whole Blood samples are obtained from donors with clinically diagnosed Skin Cancer. Valuable for transcriptomic and genomic profiling, immune cell analysis, and identification of molecular drivers of tumor progression and therapy resistance.
Skin Cancer Whole Blood
Fresh Skin Cancer Whole Blood is collected from IRB-consented donors with clinically confirmed Skin Cancer. These fresh samples are ideal for immunological and translational research focused on skin cancer pathogenesis, inflammation, and biomarker discovery.
Product Features
- Fresh whole blood from clinically diagnosed Skin Cancer donors
- Custom tubes and anticoagulants available
- Collected and shipped same-day for maximum freshness
- Research Use Only (RUO)
De-identified Donor Data
- Confirmed Skin Cancer diagnosis by physician or specialist
- Demographic details: age, sex assigned at birth, ethnicity
- Medical history including allergies and infectious disease status
Applications
- Immunophenotyping of immune cell populations in skin cancer
- Gene expression and transcriptomic analysis
- Inflammatory marker and cytokine profiling
- Drug response and mechanism-of-action studies
Compliance and Quality
- IRB-approved protocols and electronic informed consent
- HIPAA-compliant data management
Ordering and Customization
Skin Cancer whole blood is available in a range of standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Whole Blood
Frequently Asked Questions
1 Answer
Collected and shipped same-day – local pickup may be available. For more information, request a quote or contact: LearnMore@sanguinebio.com
1 Answer
YES – The same-day program processes and ships samples on the day of collection, ensuring delivery well within 48 hours for the designated service areas.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.